Ocular Therapeutix, Inc.
NASDAQ · us_market
No AI insight generated yet for this ticker.
Ocular Therapeutix, Inc., a biopharmaceutical company, engages in the development and commercialization of therapies for retinal diseases and other eye conditions using its bioresorbable hydrogel-based formulation technology in the United States. The company markets DEXTENZA, a dexamethasone ophthalmic insert to treat post-surgical ocular inflammation and pain following ophthalmic surgery, as well as allergic conjunctivitis. It is also developing AXPAXLI, an axitinib intravitreal hydrogel that is in phase 3 clinical trials for the treatment of wet age-related macular degeneration and non-proliferative diabetic retinopathy; OTX-TIC, a travoprost intracameral hydrogel, which has completed phase 2 clinical trials for the treatment of open-angle glaucoma or ocular hypertension. The company has a license agreement and collaboration with AffaMed Therapeutics Limited for the development and commercialization of DEXTENZA and OTX-TIC. Ocular Therapeutix, Inc. was incorporated in 2006 and is headquartered in Bedford, Massachusetts.
| Fund | Style | Shares | Value | % of Port | Change vs. last quarter | Period |
|---|---|---|---|---|---|---|
| FidelityFMR | fundamental | 32.65M | $276.58M | 0.01% | Added+2.7% | 2026-03-31 |
| Citadel | multi-strat | 5.53M | $46.88M | 0.06% | Added+444.6% | 2026-03-31 |
| StateStreet | passive | 4.71M | $39.88M | 0.00% | Added+12.2% | 2026-03-31 |
| TwoSigma | quant | 1.83M | $15.50M | 0.01% | Added+380.7% | 2026-03-31 |
| RenTech | quant | 1.15M | $9.72M | 0.02% | Added+45.1% | 2026-03-31 |
| DEShaw | quant | 218.5K | $1.85M | 0.00% | Trimmed-81.1% | 2026-03-31 |
| Wellington | fundamental | 75.4K | $638.28K | 0.00% | Added+1.4% | 2026-03-31 |
| TRowePrice | fundamental | 5.90M | $49.95K | 0.01% | Added+3338.1% | 2026-03-31 |
| Report Date | EPS Estimate | EPS Actual | Surprise |
|---|---|---|---|
| 2026-08-05upcoming | -0.41 | — | — |
| 2026-05-05 | -0.31 | -0.40 | -27.59% |
| 2026-02-05 | -0.34 | -0.29 | +13.86% |
| 2025-11-04 | -0.35 | -0.38 | -9.61% |
| 2025-08-05 | -0.35 | -0.39 | -10.73% |
| 2025-05-05 | -0.29 | -0.38 | -29.25% |
| 2025-03-03 | -0.22 | -0.29 | -31.82% |
| 2024-11-14 | -0.21 | -0.22 | -6.45% |
| 2024-08-07 | -0.21 | -0.26 | -21.88% |
| 2024-05-07 | -0.18 | -0.24 | -33.33% |
| 2024-03-11 | -0.22 | -0.35 | -60.92% |
| 2023-11-07 | -0.25 | -0.19 | +25.89% |
| 2023-08-07 | -0.29 | -0.26 | +10.34% |
| 2023-05-08 | -0.24 | -0.31 | -29.72% |
| 2023-03-06 | -0.24 | -0.27 | -13.64% |
| 2022-11-07 | -0.21 | -0.30 | -39.30% |
| 30d | 90d | YTD | 1y | |
|---|---|---|---|---|
| OCUL | -4.45% | -16.26% | -25.78% | +12.48% |
| XLV | +2.97% | -4.64% | -3.44% | +12.69% |
| Alpha (stock − sector) | -7.42% | -11.63% | -22.34% | -0.20% |